Get the Stockscreener App
188.13
1.09%
-2.08
After Hours:
188.13
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $188.13, with a volume of 1.35M.
It is down -1.09% in the last 24 hours and up +18.38% over the past month.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
See More
Previous Close:
$190.21
Open:
$189.29
24h Volume:
1.35M
Relative Volume:
0.60
Market Cap:
$51.24B
Revenue:
$21.37B
Net Income/Loss:
$1.41B
P/E Ratio:
47.70
EPS:
3.9437
Net Cash Flow:
$3.07B
1W Performance:
+0.27%
1M Performance:
+18.38%
6M Performance:
+6.60%
1Y Performance:
-3.72%
1-Day Range:
$187.73
$190.41
1-Week Range:
$186.95
$193.07
52-Week Range:
$140.11
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
188.13 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
367.07 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
ALC
Alcon Inc
|
72.23 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
235.76 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.65 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Resumed | Goldman | Neutral |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
A continuous monitoring medtech vet charts the course to a less-invasive future - Medical Design & Outsourcing
16,962 Shares in Becton, Dickinson and Company $BDX Acquired by Wealthfront Advisers LLC - MarketBeat
Park West Asset Management LLC's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Tocqueville Asset Management L.P. Raises Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Flossbach Von Storch SE Sells 8,875 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson stock extends its August rally as shares trade close to 52-week high - Ad-hoc-news.de
Danske Bank A S Decreases Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Foster & Motley Inc. Purchases New Position in Becton, Dickinson and Company $BDX - MarketBeat
A Look at Becton Dickinson & Co (BDX) After 3.8% Gain -- GF Value $190.44 vs Price $187.60 - GuruFocus
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Becton Dickinson and Co stock hits 52-week high at 187.5 USD - Investing.com Nigeria
Becton, Dickinson and Company (NYSE:BDX) Reaches New 1-Year HighWhat's Next? - MarketBeat
What's Going On With Becton Dickinson Stock Wednesday? - Benzinga
Mitsubishi UFJ Asset Management Co. Ltd. Makes New Investment in Becton, Dickinson and Company $BDX - MarketBeat
Pallas Capital Advisors LLC Takes $920,000 Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Sold by Great Lakes Advisors LLC - MarketBeat
Deutsche Bank AG Purchases Shares of 1,349,544 Becton, Dickinson and Company $BDX - MarketBeat
BlackRock Inc. Purchases Shares of 24,592,166 Becton, Dickinson and Company $BDX - MarketBeat
K.J. Harrison & Partners Inc Takes $1.59 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Nuance Investments LLC Acquires Shares of 96,615 Becton, Dickinson and Company $BDX - MarketBeat
Trust Co. of Vermont Takes $4.99 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Plato Investment Management Ltd Purchases Shares of 11,485 Becton, Dickinson and Company $BDX - MarketBeat
OneDigital Investment Advisors LLC Purchases Shares of 8,473 Becton, Dickinson and Company $BDX - MarketBeat
Commerzbank Aktiengesellschaft FI Invests $2.39 Million in Becton, Dickinson and Company $BDX - MarketBeat
Flputnam Investment Management Co. Takes $1.52 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
7,783 Shares in Becton, Dickinson and Company $BDX Purchased by Global Retirement Partners LLC - MarketBeat
Early Alert: Convenience Kit Issue from Becton Dickinson - fda.gov
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire - Finviz
Jeffrey Silvestri to Retire as Senior Vice President, Global Head of Quality of Becton, Dickinson and Company in October 2026 - marketscreener.com
Are Wall Street Analysts Predicting Becton, Dickinson and Company Stock Will Climb or Sink? - Yahoo Finance
Becton, Dickinson and Company (BDX) Investor Outlook: Navigating Growth Potential and Dividend Stability - DirectorsTalk Interviews
Beverly Hills Private Wealth LLC Takes $3.35 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
SFE Investment Counsel Invests $2.67 Million in Becton, Dickinson and Company $BDX - MarketBeat
Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $208 - Moomoo
90,788 Shares in Becton, Dickinson and Company $BDX Acquired by Oppenheimer Asset Management Inc. - MarketBeat
Bryn Mawr Trust Advisors LLC Purchases Shares of 46,332 Becton, Dickinson and Company $BDX - MarketBeat
Insider Selling: Becton, Dickinson and Company (NYSE:BDX) CEO Sells $768,120.00 in Stock - MarketBeat
Becton Dickinson (BDX) CEO exercises 43,278 SARs and disposes shares under 10b5-1 plan - Stock Titan
Why Is Becton Dickinson (BDX) Getting Fresh Attention Today? - simplywall.st
Becton, Dickinson: An Earnings Beat Again As Diverse Clinical Portfolio Keeps On Growing - Seeking Alpha
Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products - benzinga.com
Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $208 - Moomoo
Becton Dickinson EVP Roland Goette sells $440,887 in stock - Investing.com
Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating - marketscreener.com
RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating - marketscreener.com
Becton, Dickinson and Company $BDX Shares Purchased by Handelsbanken Fonder AB - MarketBeat
Becton Dickinson & Co Insider Sold Shares Worth $440,888, According to a Recent SEC Filing - marketscreener.com
Becton Dickinson (NYSE: BDX) EVP Roland Goette sells 2,438 shares at $180.84 - Stock Titan
UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating - marketscreener.com
UBS Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $205 - Moomoo
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):